| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 142.34B | 139.82B | 143.39B | 163.22B | 156.05B | 156.52B |
| Gross Profit | 13.72B | 15.16B | 13.14B | 7.61B | 11.99B | 15.19B |
| EBITDA | 5.99B | 7.58B | 6.71B | 97.00M | 6.27B | 10.88B |
| Net Income | 3.45B | 4.56B | 3.69B | -2.07B | 2.91B | 5.99B |
Balance Sheet | ||||||
| Total Assets | 142.09B | 155.90B | 149.84B | 165.08B | 170.66B | 169.62B |
| Cash, Cash Equivalents and Short-Term Investments | 27.48B | 24.81B | 21.67B | 17.53B | 28.07B | 19.78B |
| Total Debt | 6.87B | 8.35B | 6.92B | 13.02B | 6.98B | 7.56B |
| Total Liabilities | 71.91B | 78.67B | 76.78B | 96.16B | 97.42B | 95.13B |
| Stockholders Equity | 68.61B | 75.50B | 71.54B | 67.66B | 72.15B | 73.65B |
Cash Flow | ||||||
| Free Cash Flow | 6.21B | 3.49B | 11.30B | -13.32B | 11.49B | 3.35B |
| Operating Cash Flow | 6.29B | 3.89B | 11.78B | -11.54B | 12.86B | 5.54B |
| Investing Cash Flow | -493.00M | 153.00M | -876.00M | -996.00M | 758.00M | -2.19B |
| Financing Cash Flow | -3.25B | -1.16B | -6.62B | 1.73B | -5.43B | -11.97B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ¥66.11B | 11.09 | ― | 3.55% | 3.44% | 5.35% | |
67 Neutral | ¥64.94B | 10.30 | ― | 2.56% | 2.50% | 21.22% | |
66 Neutral | ¥66.30B | 14.37 | ― | 3.84% | -2.49% | 23.25% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥62.23B | 10.49 | ― | 0.79% | 0.81% | -53.76% | |
58 Neutral | ¥69.85B | 12.71 | ― | 2.73% | -2.86% | 50.42% | |
54 Neutral | ¥43.99B | 9.90 | ― | 2.84% | 21.15% | 18.25% |